A Case of Sunitinib-Induced Destructive Thyroiditis
Endocrinology and Metabolism
;
: 68-71, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-107383
ABSTRACT
Sunitinib is a multi-targeted tyrosine-kinase inhibitor used for gastrointestinal stromal tumors and renal cell carcinoma (RCC). Several recent studies have reported sunitinib-induced hypothyroidism and thyroid dysfunction; however, the underlying mechanisms are not clear. Here, we report a patient with metastatic RCC, who developed destructive thyroidtis due to sunitinib treatment. The course followed in this case may be useful in understanding the clinical course of sunitinib-induced thyroiditis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pirroles
/
Glándula Tiroides
/
Tiroiditis
/
Carcinoma de Células Renales
/
Tumores del Estroma Gastrointestinal
/
Hipotiroidismo
/
Indoles
Límite:
Humanos
Idioma:
Coreano
Revista:
Endocrinology and Metabolism
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS